Polycystic Ovarian Syndrome (PCOS) Biomarker Evaluation Study

Abroad (travel likely)Recruiting

Conditions

Polycystic Ovarian Syndrome (PCOS)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Department of Obstetrics and Gynecology, University Erlangen Hospital, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany, Erlangen, Germany
Contact: Study coordinator (Laura Lotz, Dr) · laura.lotz@uk-erlangen.de · +49 9131 85 44023
Contact: Study coordinator (Ralf Dittrich, Prof) · ralf.dittrich@uk-erlangen.de

Study leads

Ralf Dittrich, Prof.
Principal Investigator
University Hospital Erlangen

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Bicalutamide Therapy in Young Women With NAFLD and PCOS

NAFLD · PCOS

Abroad (travel likely)RecruitingPHASE1

San Francisco, United States

Clinical Application of Serum Anti-Müllerian Hormone (AMH) Measurements

Anti-Müllerian Hormone · Polycystic Ovarian Syndrome · Premature Ovarian Insufficiency

Abroad (travel likely)Recruiting

Hong Kong, Hong Kong

Comparative Study Between HOMA1-IR and HOMA2-IR in Prediction of Ovulation Outcome in Women With PCOS

Polycystic Ovarian Syndrome (PCOS)

Abroad (travel likely)Recruiting

Cairo, Egypt

Exogenous Ketone Supplementation in Females with Polycystic Ovary Syndrome

PCOS

Abroad (travel likely)Recruiting

Montreal, Canada